Heparin-Induced Renal Tubular Acidosis Masquerading as Hyperkalemia in a SARS-CoV-2 (COVID-19) Patient: A Case Report

Type 4 renal tubular acidosis (RTA) is a type of metabolic acidosis characterized by hyperchloremia and hyperkalemia resulting from the reduction in and/or resistance to aldosterone. RTA can be caused by multiple different medications including angiotensin-converting enzyme (ACE) inhibitor/angiotens...

Descripción completa

Detalles Bibliográficos
Autores principales: Baleguli, Vidya, Mahmood, Riaz, Herrera, Martin, Raybon-Rojas, Erine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747980/
https://www.ncbi.nlm.nih.gov/pubmed/35028212
http://dx.doi.org/10.7759/cureus.20312
_version_ 1784630962849579008
author Baleguli, Vidya
Mahmood, Riaz
Herrera, Martin
Raybon-Rojas, Erine
author_facet Baleguli, Vidya
Mahmood, Riaz
Herrera, Martin
Raybon-Rojas, Erine
author_sort Baleguli, Vidya
collection PubMed
description Type 4 renal tubular acidosis (RTA) is a type of metabolic acidosis characterized by hyperchloremia and hyperkalemia resulting from the reduction in and/or resistance to aldosterone. RTA can be caused by multiple different medications including angiotensin-converting enzyme (ACE) inhibitor/angiotensin receptor blocker (ARB), potassium-sparing diuretics, and heparin. In this case, we discuss renal tubular acidosis caused by heparin use for the prevention of thromboembolic disease in COVID-19 infections.
format Online
Article
Text
id pubmed-8747980
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-87479802022-01-12 Heparin-Induced Renal Tubular Acidosis Masquerading as Hyperkalemia in a SARS-CoV-2 (COVID-19) Patient: A Case Report Baleguli, Vidya Mahmood, Riaz Herrera, Martin Raybon-Rojas, Erine Cureus Internal Medicine Type 4 renal tubular acidosis (RTA) is a type of metabolic acidosis characterized by hyperchloremia and hyperkalemia resulting from the reduction in and/or resistance to aldosterone. RTA can be caused by multiple different medications including angiotensin-converting enzyme (ACE) inhibitor/angiotensin receptor blocker (ARB), potassium-sparing diuretics, and heparin. In this case, we discuss renal tubular acidosis caused by heparin use for the prevention of thromboembolic disease in COVID-19 infections. Cureus 2021-12-09 /pmc/articles/PMC8747980/ /pubmed/35028212 http://dx.doi.org/10.7759/cureus.20312 Text en Copyright © 2021, Baleguli et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Baleguli, Vidya
Mahmood, Riaz
Herrera, Martin
Raybon-Rojas, Erine
Heparin-Induced Renal Tubular Acidosis Masquerading as Hyperkalemia in a SARS-CoV-2 (COVID-19) Patient: A Case Report
title Heparin-Induced Renal Tubular Acidosis Masquerading as Hyperkalemia in a SARS-CoV-2 (COVID-19) Patient: A Case Report
title_full Heparin-Induced Renal Tubular Acidosis Masquerading as Hyperkalemia in a SARS-CoV-2 (COVID-19) Patient: A Case Report
title_fullStr Heparin-Induced Renal Tubular Acidosis Masquerading as Hyperkalemia in a SARS-CoV-2 (COVID-19) Patient: A Case Report
title_full_unstemmed Heparin-Induced Renal Tubular Acidosis Masquerading as Hyperkalemia in a SARS-CoV-2 (COVID-19) Patient: A Case Report
title_short Heparin-Induced Renal Tubular Acidosis Masquerading as Hyperkalemia in a SARS-CoV-2 (COVID-19) Patient: A Case Report
title_sort heparin-induced renal tubular acidosis masquerading as hyperkalemia in a sars-cov-2 (covid-19) patient: a case report
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747980/
https://www.ncbi.nlm.nih.gov/pubmed/35028212
http://dx.doi.org/10.7759/cureus.20312
work_keys_str_mv AT balegulividya heparininducedrenaltubularacidosismasqueradingashyperkalemiainasarscov2covid19patientacasereport
AT mahmoodriaz heparininducedrenaltubularacidosismasqueradingashyperkalemiainasarscov2covid19patientacasereport
AT herreramartin heparininducedrenaltubularacidosismasqueradingashyperkalemiainasarscov2covid19patientacasereport
AT raybonrojaserine heparininducedrenaltubularacidosismasqueradingashyperkalemiainasarscov2covid19patientacasereport

Ejemplares similares